Skip to content

VISIGLIDE G-240-2527SRecalls & reported problems

Terumo Corporation · VISIGLIDE Single Use Guidewire · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
4
Deaths reported
0
Injuries reported
4
Recalls naming it
0

Summary

The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 04953170282744), received between Dec 14, 2021 and Oct 30, 2024 — classified as 4 injuries.

The most frequently reported specific device problem is “Break” (3 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 2 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 1 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Break3
  • Adverse Event Without Identified Device or Use Problem1
  • Detachment of Device or Device Component1

Patient problems

  • No Clinical Signs, Symptoms or Conditions3
  • Pancreatitis1

Recent adverse event reports

The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.

  • InjuryOct 30, 2024Break; Detachment of Device or Device Component; Break; Detachment of Device or Device Component

    IT WAS REPORTED THAT A PART OF THE GUIDEWIRE BROKE OFF INTO THE PATIENT DURING A THERAPEUTIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) PROCEDURE. THE BROKEN WIRE WAS REMOVED, AND THE PROCEDURE WAS COMPLETED WITH THE SAME DEVICE. THE PROCEDURE AND ANESTHESIA WERE EXTENDED BY APPROXIMATELY 5 MINUTES. THERE WERE NO REPORTS OF PATIENT HARM.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 20566474 ↗
  • InjuryJan 12, 2024Break; Break

    A USER FACILITY REPORTED TO OLYMPUS THAT THE SINGLE USE GUIDEWIRE TIP BROKE DURING AN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAM AND WAS SUCCESSFULLY RETRIEVED FROM THE PATIENT. ADDITIONAL INFORMATION WAS REQUESTED MULTIPLE TIMES BUT WAS NOT RECEIVED. THIS EVENT REQUIRES TWO REPORTS AS THE REPORTER WAS UNSURE WHICH DEVICE FAILED (TWO SEPARATE LOT NUMBERS). PATIENT IDENTIFIER (B)(6) IS FOR LOT 36K. PATIENT IDENTIFIER (B)(6) IS FOR LOT 33K. THIS REPORT IS FOR (B)(6).

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18504188 ↗
  • InjuryJan 12, 2024Break; Break

    A USER FACILITY REPORTED TO OLYMPUS THAT THE SINGLE USE GUIDEWIRE TIP BROKE DURING AN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAM AND WAS SUCCESSFULLY RETRIEVED FROM THE PATIENT. ADDITIONAL INFORMATION WAS REQUESTED MULTIPLE TIMES BUT WAS NOT RECEIVED. THIS EVENT REQUIRES TWO REPORTS AS THE REPORTER WAS UNSURE WHICH DEVICE FAILED (TWO SEPARATE LOT NUMBERS). PATIENT IDENTIFIER (B)(6) IS FOR LOT 36K. PATIENT IDENTIFIER (B)(6) IS FOR LOT 33K. THIS REPORT IS FOR (B)(6).

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18504013 ↗
  • InjuryDec 14, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    AN ARTICLE WAS PUBLISHED IN AN AMERICAN SCHOLARLY JOURNAL (PLOSONE). IT WAS ABOUT A RETROSPECTIVE ANALYSIS OF A TOTAL OF 85 PATIENTS WHO UNDERWENT ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) AND ENDOSCOPIC ULTRASOUND (EUS) FOR SUSPECTED BILIARY STENOSIS AT THE (B)(6) MEDICAL CENTER IN (B)(6). IN THAT ARTICLE, IT WAS REPORTED THAT THERE WERE POST-PROCEDURE ACUTE PANCREATITIS AS ADVERSE EVENTS. SINCE VISIGLIDE WAS INCLUDED IN THE DEVICE USED, IT WAS TAKEN UP AS COMPLIMENTS BY OUR US SUBSIDIARY. HOWEVER, THERE WAS NO MENTION OF THE RELATIONSHIP BETWEEN ADVERSE EVENTS AND VISIGLIDE, AND THERE WAS NO REPORT OF DEVICE MALFUNCTION. THE PATIENT WAS HARMED; IT WAS NOT SERIOUS INJURY.

    Patient problems: Pancreatitis

    MAUDE report 13001103 ↗

Other Endoscopic guidewire, gastroenterology-urology devices

All Endoscopic guidewire, gastroenterology-urology devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page